A Study to Evaluate the Safety and Efficacy of Docetaxel for Injection (Albumin-bound)in Different Dose Regimens in Patients With Advanced Solid Tumors
Clinical trial NCT05114915 · UNKNOWN
Trial details
- NCT number
- NCT05114915
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-07
- Primary completion
- 2023-10-01
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.